Pyrrolo[2,1-f][1,2,4]triazine: a promising fused heterocycle to target kinases in cancer therapy

被引:9
作者
Singh, Sarbjit [1 ]
Utreja, Divya [2 ]
Kumar, Vimal [3 ]
机构
[1] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA
[2] Punjab Agr Univ, Dept Chem, Ludhiana 141004, Punjab, India
[3] Dr BR Ambedkar Natl Inst Technol NIT, Dept Chem, Jalandhar 144011, Punjab, India
关键词
Pyrrolo[2,1-f][1,2,4]triazine; Kinase inhibition; Fused heterocycles; Cancer; Targeted therapy; PYRROLOTRIAZINE DUAL INHIBITORS; HEDGEHOG SIGNALING PATHWAY; CELL LUNG-CANCER; HIGHLY POTENT; ANTIPROLIFERATIVE ACTIVITY; HORMONE-THERAPY; JAK INHIBITORS; IN-VITRO; DISCOVERY; EGFR;
D O I
10.1007/s00044-021-02819-1
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Cancer is the second leading cause of death worldwide responsible for about 10 million deaths per year. To date several approaches have been developed to treat this deadly disease including surgery, chemotherapy, radiation therapy, hormonal therapy, targeted therapy, and synthetic lethality. The targeted therapy refers to targeting only specific proteins or enzymes that are dysregulated in cancer rather than killing all rapidly dividing cells, has gained much attention in the recent past. Kinase inhibition is one of the most successful approaches in targeted therapy. As of 30 March 2021, FDA has approved 65 small molecule protein kinase inhibitors and most of them are for cancer therapy. Interestingly, several kinase inhibitors contain one or more fused heterocycles as part of their structures. Pyrrolo[2,1-f][1,2,4]triazine is one the most interesting fused heterocycle that is an integral part of several kinase inhibitors and nucleoside drugs viz. avapritinib and remdesivir. This review articles focus on the recent advances made in the development of kinase inhibitors containing pyrrolo[2,1-f][1,2,4]triazine scaffold.
引用
收藏
页码:1 / 25
页数:25
相关论文
共 50 条
  • [21] Pot, atom and step economic synthesis: a diversity-oriented approach to construct 2-substituted pyrrolo[2,1-f][1,2,4]triazin-4(3H)-ones
    Xiang, Haoyue
    Chen, Yanhong
    He, Qian
    Xie, Yuyuan
    Yang, Chunhao
    RSC ADVANCES, 2013, 3 (17) : 5807 - 5810
  • [22] Antimicrobial studies of some novel quinazolinones fused with [1,2,4]-triazole, [1,2,4]-triazine and [1,2,4,5]-tetrazine rings
    Pandey, Sarvesh Kumar
    Singh, Abhishek
    Singh, Ashutosh
    Nizamuddin
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2009, 44 (03) : 1188 - 1197
  • [23] Pyrrolo[2,1-c][1,2,4]triazines from 2-diazopyrroles:: synthesis and antiproliferative activity
    Diana, P
    Barraja, P
    Lauria, A
    Montalbano, A
    Almerico, AM
    Dattolo, G
    Cirrincione, G
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2002, 37 (03) : 267 - 272
  • [24] Synthesis of furo[2′,3′:4,5]pyrrolo[1,2-d][1,2,4]triazine derivatives and their antibacterial activity
    Zemanova, Ivana
    Gasparova, Renata
    Kraic, Filip
    Kruzlicova, Dasa
    Maliar, Tibor
    Bohac, Andrej
    Addova, Gabriela
    ARKIVOC, 2017, : 184 - 193
  • [25] Microwave Assisted Synthesis of Pyrazolo[1,5-a]pyrimidine, Triazolo[1,5-a]pyrimidine, Pyrimido[1,2-a]benzimdazole, Triazolo[5,1-c][1,2,4]triazine and Imidazo[2,1-c][1,2,4]triazine
    Fahim, Asmaa
    Farag, Ahmad
    Shaaban, Mohamed
    Ragab, Eman
    CURRENT MICROWAVE CHEMISTRY, 2018, 5 (02) : 111 - 119
  • [26] Molecular Structure and Supramolecular Architecture of Brivanib: (R)-1-(4-(4-Fluoro-2-methyl-1H-indol-5-yloxy)-5-methylpyrrolo[2,1-f] [1,2,4]triazin-6-yloxy)propan-2-ol
    Cai, Jie
    Zhang, Ruirui
    CRYSTALLOGRAPHY REPORTS, 2022, 67 (07) : 1183 - 1186
  • [27] The activity of pyrazolo[4,3-e][1,2,4]triazine and pyrazolo[4,3-e]tetrazolo[1,5-b][1,2,4]triazine sulphonamide derivatives in monolayer and spheroid breast cancer cell cultures
    Szymanowska, Anna
    Radomska, Dominika
    Czarnomysy, Robert
    Mojzych, Mariusz
    Kotwica-Mojzych, Katarzyna
    Bielawski, Krzysztof
    Bielawska, Anna
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2024, 39 (01)
  • [28] Identification of antitumour activity of novel derivatives of 8-aryl-2,6,7,8-tetrahydroimidazo[2,1-c][1,2,4]triazine-3,4-dione and 8-aryl-4-imino-2,3,7,8-tetrahydroimidazo-[2,1-c][1,2,4]triazin-3(6H)-one
    Sztanke, Krzysztof
    Pasternak, Kazimierz
    Rzymowska, Jolanta
    Sztanke, Malgorzata
    Kandefer-Szerszen, Martyna
    Dybala, Izabela
    Koziol, Anna E.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2007, 15 (08) : 2837 - 2849
  • [29] Exploration of novel heterofused 1,2,4-triazine derivative in colorectal cancer
    Hermanowicz, Justyna Magdalena
    Szymanowska, Anna
    Sieklucka, Beata
    Czarnomysy, Robert
    Pawlak, Krystyna
    Bielawska, Anna
    Bielawski, Krzysztof
    Kalafut, Joanna
    Przybyszewska, Alicja
    Surazynski, Arkadiusz
    Rivero-Muller, Adolfo
    Mojzych, Mariusz
    Pawlak, Dariusz
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2021, 36 (01) : 535 - 548
  • [30] Isoindolo[2,1-c]benzo[1,2,4]triazines:: A new ring system with antiproliferative activity
    Diana, Patrizia
    Martorana, Annamaria
    Barraja, Paola
    Lauria, Antonino
    Montalbano, Alessandra
    Almerico, Anna Maria
    Dattolo, Gaetano
    Cirrincione, Girolamo
    BIOORGANIC & MEDICINAL CHEMISTRY, 2007, 15 (01) : 343 - 349